痴呆症赋权和行动的创新:为受忽视的社区提供RCT
Karen I Fredriksen-Goldsen1, Linda Teri2, Hyun-Jun Kim1
1Goldsen Institute, School of Social Work, University of Washington, Washington, DC, USA.
Journal of the American Geriatrics Society
|December 12, 2025
概括
痴呆症赋权和行动创新 (IDEA) 干预措施在改善痴呆症性和性别少数群体成年人的身体活动和生活质量方面表现出持续的有效性. 文化定制的痴呆症护理对解决健康差异有希望.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 痴呆症护理干预措施往往忽视了受服务不足的人群所面临的差异.
- 性和性别少数群体 (SGM) 的痴呆症成年人经历了独特的挑战.
- 痴呆症赋权和行动创新 (IDEA) 的干预措施是为了弥补这些差距而制定的.
研究的目的:
- 为了比较文化定制的IDEA干预与SGM成年痴呆患者及其护理伙伴的标准干预 (s-RDAD) 的疗效.
- 评估这两种干预措施对身体活动,生活质量,身体功能和资源素养的影响.
主要方法:
- 一个双臂,单盲,随机对照试验 (RCT) 涉及161个双 (痴呆症患者/护理伙伴).
- 分散的多个基线设计比较IDEA和s-RDAD.
- 治疗后评估的结果,以及30周和56周的随访.
主要成果:
- 30周后,IDEA护理合作伙伴的社区资源素养显著提高.
- 这两种干预措施都改善了痴呆症患者治疗后的身体活动和生活质量.
- 与s-RDAD.不同的是,IDEA在30周后显示身体活动和生活质量持续改善.
结论:
- 根据文化定制的IDEA干预措施是有效的,并证明了持续的益处.
- 对痴呆症干预措施的文化定制有望减少健康差异.
- 需要进一步的研究来将IDEA转化为更广泛的社区环境.
更多相关视频
07:40Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
3.8K
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
1.5K
相关概念视频
Community Based Intervention
258
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
258
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Intellectual Disability
595
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
595
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
